InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Andreas Gerward. Director active across 1 company, notably Stayble Therapeutics AB. Cumulatively, 1 filings have been logged. History available since 4 February 2021. The latest transaction was filed on 4 February 2021 (Other). Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration